Multimodal Analgesia in Small Animal Surgery: Opioid-Sparing Strategies

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Multimodal analgesia leverages the principle of interrupting multiple pain pathways simultaneously to achieve superior pain relief and reduce reliance on any single drug class, particularly opioids. This approach targets transduction, transmission, modulation, and perception of pain through distinct pharmacologic mechanisms.
• Key non-opioid drug classes integral to opioid-sparing strategies include NSAIDs (COX inhibition), local anesthetics (sodium channel blockade), alpha-2 agonists (central modulation), ketamine (NMDA antagonism), and gabapentinoids (calcium channel modulation). Preemptive administration before surgical insult is crucial to prevent central sensitization.
• Regional anesthetic techniques, such as epidural, peripheral nerve blocks, and wound infiltration, are highly effective in providing localized analgesia with minimal systemic effects, significantly reducing opioid requirements. These techniques necessitate precise anatomic knowledge and aseptic protocols.
• Preoperative patient assessment is critical for stratifying risk and selecting appropriate analgesic modalities, particularly evaluating renal, hepatic, and gastrointestinal status for NSAID eligibility, and coagulation status for regional techniques. Feline patients require specific consideration due to unique metabolism and subtle pain presentation.
• Opioids remain essential for managing severe or breakthrough pain, but should not be the default first-line agent for all surgical patients. Their use should be reserved and titrated to effect, with a clear rescue protocol established preoperatively.
• Comprehensive documentation of analgesic plans, administered drugs, routes, timing, and pain scores is vital for continuity of care, medicolegal purposes, and quality improvement, alongside clear communication with owners regarding postoperative expectations and monitoring.

This article provides a clinical framework for reducing perioperative opioid reliance in dogs and cats through multimodal analgesic planning. It is written for practicing veterinarians who perform or supervise surgical procedures and who seek evidence-informed alternatives to opioid-dominant protocols. The content addresses the physiological rationale for opioid sparing, the role of non-opioid drug classes, regional anesthetic techniques, and practical considerations for patient selection and monitoring. Drug doses are deliberately omitted, current formulary and label references must be consulted before clinical use.

Opioid-sparing analgesia rests on a straightforward premise: pain is mediated through multiple parallel pathways, and interrupting several of them simultaneously produces superior analgesia with lower doses of any single agent. The 2022 ISFM Consensus Guidelines on the Management of Acute Pain in Cats identify preventive and multimodal analgesia, including local anesthesia, as core principles of feline pain management. The same logic applies to dogs. When non-opioid analgesics provide meaningful baseline coverage, opioid requirements fall, and with them the adverse effects that delay recovery: ileus, nausea, sedation, dysphoria, and respiratory depression.

The clinical question is not whether opioids remain useful. They do, particularly for severe or breakthrough pain. The question is whether they must be the default first-line agent for every surgical patient. The evidence increasingly suggests they should not be. A systematic review of perioperative pain management in cardiac surgery found that opioids remain the most extensively used therapy despite limited trials evaluating alternatives such as paracetamol, and that regional techniques can effectively treat pain without demonstrated impact on major outcomes. The parallel in small animal practice is instructive: tradition, not evidence, sustains many opioid-heavy protocols.

At a Glance

Physiology of Pain and the Rationale for Multimodal Therapy

Surgical trauma generates pain through four principal mechanisms: transduction at nociceptors, transmission along peripheral nerves, modulation at the spinal cord, and perception in higher brain centers. Each mechanism offers a distinct pharmacologic target. NSAIDs reduce prostaglandin synthesis at the site of tissue injury, local anesthetics block sodium channels to prevent signal transmission, alpha-2 agonists act at spinal and supraspinal receptors to modulate descending inhibitory pathways, and ketamine antagonizes NMDA receptors to limit central sensitization. Opioids, for all their efficacy, act primarily at mu receptors in the spinal cord and brain. A protocol that engages several of these targets simultaneously achieves broader coverage than any single agent.

Central sensitization deserves particular attention. Uncontrolled nociceptive input during surgery can produce wind-up, a state of heightened spinal cord excitability that amplifies postoperative pain and increases analgesic requirements. Preventive analgesia, the administration of analgesics before the surgical stimulus, aims to blunt this process. The AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats emphasize anesthetic planning that accounts for the entire perioperative period, including preemptive analgesic selection. Local anesthetics and NSAIDs given before incision reduce the afferent barrage that drives central sensitization.

The Evidence Base for Opioid Sparing

Clinical evidence for opioid-sparing multimodal protocols in small animals is growing but uneven. The WSAVA Global Pain Council Guidelines endorse multimodal treatment as the standard of care for companion animal pain. However, much of the supporting literature derives from human medicine, laboratory animal research, or extrapolation across species. A systematic scoping review of experimental craniotomy in mice and rats found that reporting of multimodal analgesia remained low between 2009 and 2019, with monotherapy more common than combination approaches. This gap between recommended practice and actual clinical behavior is likely present in small animal practice as well.

The human literature offers useful direction. A narrative review of perioperative anesthesia care and tumor progression noted that preliminary evidence suggests NSAIDs should be an essential part of multimodal analgesia, while basic science data suggest an antitumor effect induced by local anesthetics. The same review found inconclusive evidence regarding whether regional anesthesia reduces cancer recurrence, and noted that refined animal models show opioids can be used safely for perioperative pain management. These findings do not translate directly to dogs and cats, but they support the safety and potential benefit of reducing opioid exposure when alternatives are available.

NSAIDs in the Perioperative Period

Non-steroidal anti-inflammatory drugs are the most widely used non-opioid analgesics in small animal surgery. They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis at sites of inflammation and producing both analgesic and anti-inflammatory effects. Their efficacy in controlling surgical pain is well established, and they are a logical foundation for an opioid-sparing protocol in patients without contraindications.

The principal concern with perioperative NSAID use is the potential for impaired healing. A review of the effects of NSAIDs on healing of bone, cartilage, soft tissue, wounds, flaps, and enteral anastomoses found that animal data suggest some potentially harmful effects but are contradictory in most areas studied. Human data are limited and of poor quality, with few randomized controlled trials and many cohort studies subject to confounding. The review concluded that available human data do not preclude short-term postoperative NSAID use of less than two weeks. For small animal practitioners, this supports a pragmatic approach: use NSAIDs when indicated, avoid them in patients with renal disease, gastrointestinal ulceration, coagulopathy, or hypovolemia, and limit duration to the acute postoperative period.

Local Anesthetics and Regional Techniques

Local anesthetics offer the most direct method of blocking surgical pain at its source. Wound infiltration, peripheral nerve blocks, and epidural administration can provide profound analgesia to the surgical field while producing minimal systemic effects. These techniques reduce opioid requirements more reliably than any systemic non-opioid analgesic, and they carry the additional benefit of blunting the neuroendocrine stress response to surgery.

The MSD Veterinary Manual, Professional Edition provides species-specific guidance on local anesthetic techniques and their indications. Regional anesthesia requires anatomic knowledge, appropriate equipment, and attention to maximum safe doses to avoid systemic toxicity. Ultrasound guidance has improved the accuracy and safety of peripheral nerve blocks in small animals, and practitioners who perform regular surgery should consider developing proficiency in these techniques. The evidence from human cardiac surgery, where thoracic epidural analgesia and intrathecal morphine effectively treat pain, supports the principle that regional techniques can substitute for systemic opioids when properly executed.

Preoperative Assessment and Patient Stratification

The preoperative examination determines which analgesic modalities are appropriate and which must be withheld. A structured assessment should evaluate cardiovascular and renal status, hepatic function, coagulation profile, gastrointestinal disease, and endocrine comorbidities. These systems determine NSAID eligibility, guide local anesthetic technique selection, and identify patients who will require higher opioid doses despite multimodal efforts.

Renal function deserves particular attention. Patients with azotemia, chronic kidney disease, or conditions that reduce effective circulating volume are poor candidates for NSAIDs. The same applies to patients with hepatic insufficiency, because many NSAIDs undergo hepatic metabolism and can exacerbate existing dysfunction. Coagulation status matters for both NSAID use and regional techniques. Patients with thrombocytopenia, von Willebrand disease, or anticoagulant therapy are at increased risk for bleeding complications with neuraxial blocks and deep nerve blocks.

The 2022 ISFM consensus guidelines on acute pain management in cats emphasize that analgesic drug selection must account for the type, severity, and duration of pain, the presence of comorbidities, and the avoidance of adverse effects. Feline patients present unique metabolic constraints. Their limited glucuronidation capacity alters drug clearance, and they are particularly susceptible to NSAID accumulation. Cats also hide signs of pain, which makes preemptive analgesic planning more important than reactive treatment.

Patient temperament and handling tolerance influence technique selection. A fractious cat may not permit placement of an epidural without heavy sedation, which defeats the purpose of opioid sparing. Conversely, a calm, well-socialized dog may tolerate a peripheral nerve block with minimal sedation. The assessment should therefore include a behavioral component, also a physiologic one.

Building the Multimodal Plan

The analgesic plan is constructed around three pillars: systemic non-opioid analgesics, regional techniques, and adjunctive medications. Each pillar contributes through a distinct mechanism, and the combination produces additive or synergistic effects that permit dose reduction of individual agents.

NSAIDs provide the foundation for most canine and feline surgical protocols. They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis at sites of tissue injury and in the central nervous system. The review of NSAID effects on postoperative healing notes that perioperative analgesia should be multimodal to improve pain relief and reduce opioid use, with NSAIDs serving as an important non-opioid component. The same review acknowledges that animal data suggest potentially harmful effects on bone, cartilage, and soft tissue healing, but human data are limited and do not preclude short-term postoperative use of less than two weeks.

Local anesthetics constitute the second pillar. They block sodium channels and prevent nociceptive signal transmission from the surgical site. Regional techniques range from simple incisional infiltration to ultrasound-guided nerve blocks and neuraxial administration. The perioperative anesthesia care review notes that basic science data suggest an antitumor effect induced by local anesthetics, and preliminary evidence suggests NSAIDs should be an essential part of multimodal analgesia. These findings add weight to the argument for maximizing non-opioid components in cancer surgery patients.

Adjunctive medications form the third pillar. Ketamine at subanesthetic doses provides N-methyl-D-aspartate receptor antagonism that reduces central sensitization and opioid tolerance. Dexmedetomidine produces sedation and analgesia through alpha-2 adrenergic agonism. Gabapentinoids modulate calcium channels in the dorsal horn and are useful for neuropathic components of surgical pain. These agents are not sufficient as sole analgesics for major surgery, but they meaningfully reduce opioid requirements when combined with NSAIDs and local anesthetics.

The AAHA anesthesia and monitoring guidelines provide a framework for incorporating these modalities into a coherent anesthetic plan. The guidelines emphasize that planning begins before the patient enters the hospital and continues through recovery.

Timing of Analgesic Administration

Preemptive analgesia refers to treatment administered before the surgical incision. The goal is to prevent central sensitization before nociceptive input begins. NSAIDs are typically administered preoperatively in patients without contraindications. Local anesthetics are placed before incision whenever feasible. The WSAVA global pain council guidelines endorse preventive and multimodal analgesia as core principles of pain management.

Intraoperative administration maintains the analgesic baseline established preoperatively. Redosing intervals for local anesthetics depend on the agent and technique. Ketamine infusions, when used, continue through the procedure. The anesthetist must monitor for signs of inadequate depth or breakthrough nociception, such as tachycardia, hypertension, or movement, and respond with additional analgesia instead of increasing volatile anesthetic alone.

Postoperative analgesia extends the plan into recovery. NSAIDs continue according to label duration, typically for several days. Local anesthetic techniques may be extended through catheter placement or repeat blocks. The transition to oral medications should occur as soon as the patient can tolerate oral intake. Discharge instructions must include a tapering plan and clear criteria for reassessment.

Monitoring and Rescue Analgesia

Multimodal plans reduce opioid requirements but do not eliminate them. Every patient requires a rescue protocol for breakthrough pain. The rescue agent is usually an opioid, and the dose should be calculated and available before the patient recovers from anesthesia.

Pain scoring should be performed at regular intervals using a validated instrument appropriate to the species. The 2022 ISFM guidelines note that pain assessment tools are not widely implemented in feline practice and that signs of pain in cats may be subtle. A structured scoring system reduces observer bias and documents response to treatment.

Monitoring parameters extend beyond pain scores. Respiratory rate and depth, heart rate, blood pressure, and mucous membrane color detect both inadequate analgesia and adverse drug effects. Sedation scoring is equally important, because excessive sedation may indicate opioid accumulation or residual anesthetic effect. Gastrointestinal monitoring detects NSAID-related adverse effects, particularly in patients with preexisting risk factors.

Documentation and Communication

The analgesic plan must be documented in the medical record before surgery, with modifications recorded as they occur. The record should include the agents administered, routes, timing, pain scores, and rescue interventions. This documentation serves clinical, medicolegal, and quality improvement purposes. The AVMA practice resources provide guidance on medical record standards and professional obligations.

Communication with the owner begins before surgery and continues through discharge. The owner should understand which analgesics were administered, what to expect during recovery, and when to seek reassessment. Written discharge instructions should specify the medications, administration schedule, and warning signs that warrant a return visit.

Protocol Framework

The following table summarizes analgesic modalities, their mechanisms, and typical perioperative timing. It is a framework for clinical decision-making, not a dosing reference. Current formulary and label references must be consulted for specific doses.

A sample protocol for an ovariohysterectomy in a healthy adult dog might include a preoperative NSAID, an epidural or transversus abdominis plane block with a local anesthetic, intraoperative ketamine infusion, and a rescue opioid available in recovery. The same procedure in a cat with elevated renal values would substitute the NSAID with a different non-opioid analgesic, rely more heavily on regional techniques, and accept a higher baseline opioid requirement. The MSD Veterinary Manual provides species-specific pharmacology information that supports these substitutions.

The correct plan changes with patient status, available equipment, and clinician skill. A practice without ultrasound guidance can still perform landmark-based blocks or incisional infiltration. A practice without access to certain drugs must adapt using the agents available. The principle remains constant: combine agents with different mechanisms to achieve effective analgesia while minimizing any single drug class, particularly opioids.

Recognized Complications and Early Detection

The most common failure mode in opioid-sparing protocols is inadequate analgesia that goes unrecognised until the patient is in distress. In cats, this risk is amplified because pain behavior is subtle and easily attributed to temperament or recovery from anesthesia. The 2022 ISFM consensus guidelines on acute pain management in cats emphasize that validated pain assessment tools must be applied at regular intervals, also when pain is suspected, and that preventive multimodal analgesia is a core principle instead of an optional refinement ISFM consensus guidelines on acute pain in cats.

Hypotension during anesthesia is a second recognized complication, particularly when NSAIDs, alpha-2 agonists, and locoregional blocks are combined with inhalant anesthetics. Detection requires continuous blood pressure monitoring, ideally invasive or oscillometric, with trends reviewed instead of single readings. The AAHA anesthesia and monitoring guidelines recommend that blood pressure, heart rate, respiratory rate, and depth of anesthesia be recorded at least every five minutes during the maintenance phase AAHA anesthesia and monitoring guidelines.

Delayed wound healing and impaired bone healing remain the most debated complications of perioperative NSAID use. Animal data suggest potentially harmful effects, but the findings are contradictory across most areas studied, and human data are limited and of poor quality. The available evidence does not preclude short-term postoperative NSAID use of less than two weeks, but it does justify caution in patients with fractures, enteric anastomoses, or compromised soft tissue flaps NSAID effects on postoperative healing.

Acute kidney injury is a rare but serious complication. Detection depends on pre-existing risk stratification, intraoperative blood pressure records, and postoperative monitoring of urine output and serial renal values in patients with known renal disease, hypotension, or concurrent volume depletion. Gastrointestinal ulceration is detected through appetite loss, vomiting, melena, or falling hematocrit, and is more likely in patients receiving concurrent corticosteroids.

Common Errors and Corrective Actions

Less experienced clinicians frequently rely on a single analgesic class and assume that a normal heart rate and blood pressure exclude pain. This assumption is unsafe in cats and in dogs receiving alpha-2 agonists, where cardiovascular variables are poor pain indicators. The corrective action is to use a species-appropriate composite pain scale before and after intervention, and to treat the trend, not the single observation.

A second common error is omitting local anesthesia because the clinician lacks confidence in regional techniques. The evidence base for opioid sparing is strongest when local anesthetics are included, and basic science data suggest local anesthetics may have antitumour effects in cancer surgery perioperative anesthesia care and tumor progression. The corrective action is to master a small number of high-yield blocks, such as the incisional line block, the erector spinae plane block, and the distal limb ring block, before attempting more advanced techniques.

A third error is discharging a patient on NSAID monotherapy without a rescue plan. Owners should receive written instructions that name the expected duration of analgesia, the signs that warrant re-examination, and the circumstances in which the NSAID should be stopped. The corrective action is to prescribe rescue analgesia explicitly and to schedule a follow-up examination before the expected end of the NSAID course.

Limitations of the Evidence and Divergent Expert Opinion

The evidence base for opioid-sparing strategies in small animal surgery is thinner than many clinicians assume. Most published work is extrapolated from human medicine or from laboratory animal research, and direct comparative trials in dogs and cats are scarce. A systematic review of perioperative pain management in cardiac surgery found that opioids remain the most extensively used therapy and that few trials have investigated alternatives such as paracetamol perioperative pain management in cardiac surgery. The situation in veterinary surgery is similar.

Expert opinion diverges on three points. First, the acceptable duration of perioperative NSAID therapy remains contested, with some authorities endorsing several days of treatment and others limiting use to the immediate postoperative period. Second, the role of opioids in cancer surgery is debated, with some experimental models suggesting harm and others showing that opioids can be used safely for perioperative pain management perioperative anesthesia care and tumor progression. Third, the necessity of pre-emptive analgesia is not settled, and the practical benefit of administering analgesics before incision over administering them at induction remains unclear.

Referral, Consultation, and Reporting

Referral or specialist consultation is warranted when pain cannot be controlled with escalating doses of standard analgesics, when regional techniques fail repeatedly, or when the patient has complex comorbidities such as renal disease, cardiac disease, or coagulopathy. A veterinary anesthesiologist or pain specialist should be consulted before surgery in these patients, not after complications develop.

Laboratory involvement is indicated when acute kidney injury, hepatopathy, or coagulopathy is suspected, and when serial monitoring of organ function is required during prolonged NSAID therapy. Regulatory reporting obligations vary by jurisdiction. Clinicians should be familiar with the adverse event reporting requirements of their national veterinary authority and with the pharmacovigilance expectations of their professional body AVMA practice resources. Where controlled substance use is involved, diversion or loss must be reported according to local law.

Frequently Asked Questions

How can I implement multimodal opioid-sparing analgesia when regional anesthesia equipment is unavailable?

When ultrasound or nerve stimulators are absent, rely on systemic non-opioid analgesics and simple local techniques. Injectable local anesthetics can provide incisional blocks, splash blocks, and wound infiltration without specialized equipment. Intraperitoneal lidocaine or bupivacaine administration before closure offers visceral analgesia for abdominal procedures. Epidural and spinal techniques require only standard needles and syringes, though careful attention to aseptic technique and patient positioning is essential. The 2022 ISFM consensus guidelines on acute pain management in cats emphasize that preventive multimodal analgesia, including local anesthesia, remains a core principle even in resource-limited settings. For practices building capacity, start with incisional blocks and progress to ultrasound-guided techniques as training and equipment become available.

What is the role of non-pharmacologic interventions in reducing opioid requirements?

Non-pharmacologic measures reduce nociceptive input and opioid demand. Preoperative patient handling should minimize stress, particularly in cats where gentle handling and environmental modification decrease anxiety-mediated hyperalgesia. Intraoperative warming prevents hypothermia-induced shivering and catecholamine release. Postoperative nursing care includes soft bedding, quiet recovery areas, and early ambulation where appropriate. The WSAVA Global Pain Council guidelines position environmental modification and nursing care as integral components of the multimodal pain management plan, not optional additions. These measures are inexpensive, carry minimal risk, and can meaningfully reduce the total analgesic burden when combined with pharmacologic agents.

How do I discuss opioid-sparing strategies with a client who expects opioids for their pet?

Explain that pain control is individualized and that the goal is effective analgesia, not a specific drug. Describe how combining multiple drug classes with different mechanisms provides superior pain relief with fewer side effects than a single opioid alone. Mention that non-steroidal anti-inflammatory drugs, local anesthetics, and adjuncts target different pain pathways, allowing lower doses of each drug. The AAHA anesthesia and monitoring guidelines support this framework as standard of care for dogs and cats. Reassure clients that opioids remain available when needed as rescue analgesia and that the plan includes close monitoring and adjustment. Frame the conversation around safety and recovery quality, not drug avoidance.

What should I document in the medical record regarding the analgesic plan?

Record the preoperative pain score, planned analgesic interventions with timing, and the rationale for drug selection based on patient comorbidities. Document the actual drugs administered, including local anesthetic techniques performed, with the specific anatomic site and volume used. Note physiologic parameters and serial pain scores throughout the perioperative period. Record any rescue analgesia administered, the time to administration, and the response. The AVMA practice resources emphasize that complete medical records support continuity of care and defensible clinical decisions. Documentation of client communication about the analgesic plan and expected outcomes is also appropriate.

How does the approach to opioid-sparing analgesia differ between dogs and cats?

Feline metabolism of many analgesics differs substantially from canine metabolism, particularly for glucuronidation-dependent drugs. Cats require species-specific dosing and careful selection of non-steroidal anti-inflammatory drugs, with attention to renal and hepatic status. The 2022 ISFM consensus guidelines highlight that feline pain is frequently under-recognized and that validated pain assessment tools should be used systematically. Cats also benefit more from environmental modification and cat-friendly handling to reduce stress-mediated pain amplification. Local anesthetic techniques are equally applicable in both species, but block performance may require more patience and lighter sedation in cats. Opioid-sparing strategies should never compromise analgesia in either species, and rescue protocols must be established preoperatively.

When is it appropriate to use a pure opioid-sparing protocol without any opioid?

An opioid-free protocol is appropriate for procedures with mild to moderate expected pain in patients without contraindications to non-steroidal anti-inflammatory drugs, when local anesthesia provides complete surgical site coverage, and when the patient is hemodynamically stable. Examples include dental cleanings with simple extractions, minor mass removals, and ovariectomy in healthy patients. The evidence for opioid-free anesthesia in veterinary medicine remains limited, and the literature from human cardiac surgery shows opioids remain the most extensively used therapy despite multimodal approaches. For major surgeries, major trauma, or patients with significant comorbidities, opioids should remain part of the plan as primary or rescue analgesia. Reassess the patient frequently and escalate to opioid-containing protocols if pain scores exceed treatment thresholds.

Related Clinical & Scientific Guides

• Anesthetic Machine Leak Testing and Pressure Checks: A Step-by-Step Protocol
• Anesthetic Depth Assessment: Reflexes, Eye Position, and Ventilation
• Anesthesia for Patients with Obesity: Challenges and Solutions

References and Further Reading

• Perioperative Anesthesia Care and Tumor Progression.. 2017.
• Do NSAIDs Really Interfere with Healing after Surgery?. 2021.
• Anesthesia and analgesia for experimental craniotomy in mice and rats: a systematic scoping review comparing the years 2009 and 2019.. 2023.
• Perioperative pain management in cardiac surgery: a systematic review.. 2018.
• Pain and Laboratory Animals: Publication Practices for Better Data Reproducibility and Better Animal Welfare.. 2016.
• 2022 ISFM Consensus Guidelines on the Management of Acute Pain in Cats.. 2022.
• AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats. AAHA.
• WSAVA Global Pain Council Guidelines. WSAVA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Bovine Anesthesia and Analgesia: Field Techniques and Considerations
• Multimodal Pain Management: Principles and Implementation
• Equine Anesthetic Recovery: Complications and Management Strategies
• Nerve Stimulator and Ultrasound Guidance for Regional Anesthesia in Small Animals
• Porcine Anesthesia and Analgesia: Protocols for Surgical Procedures

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.